-
FDA moves to strengthen drug safety program; Pfizer to sponsor new celecoxib clinical trial; New drug safety warnings issued.
-
Lanthanum carbonate (Fosrenol) by Shire Pharmaceuticals Group, New indication for infliximab (Remicade) by Centocor, New indication for letrozole tablets (Femara) by Novartis.
-
Inhibitex has announced that the FDA has granted Aurexis, its humanized monoclonal antibody, fast track designation.
-
-
With the flu vaccine supply cut almost in half this season, health care providers and officials are turning to antivirals to fill in the gap. No one knows, however, if the four antiviral medications amantadine (Symmetrel), rimantadine (Flumadine), zanamivir (Relenza), and oseltamivir (Tamiflu) can meet the demand either. Robert B. Couch, MD, once tried to find out from distributors about the amount of antiviral supply.
-
Part 2 of 2: Availability and Cost, Clinical Studies, Critique of Studies, Recommendations/Conclusion.
-
With the flu season upon us and only half the normal supply of vaccine available, ED managers are preparing and bracing for a greater influx of flu patients this year.
-
If the flu vaccine shortage leads to a significant surge in flu patients, maintaining optimal staff health will be critical to providing adequate care for those patients, observers agree.
-
Provide surgical masks to all patients with symptoms of a respiratory illness. Provide instructions on the proper use and disposal of masks.
-
In our November issue, EDM featured strategies and methods employed at Grady Hospital in Atlanta and University Hospital in San Antonio, which made their programs successful. We continue our series with this article.